- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Exelon is moderately cheap compared with the industry while Sempra and Dominion may be gaining some traction, analysts say.
Here are Monday's top research calls, including downgrades for Bristol-Myers Squibb, JPMorgan and Weyerhaeuser, and an upgrade for Merck.
There's a lot out there to cheer investors, Cramer says, and August could turn out to be a better month than usual.
But perhaps the economy is a bit like the Washington gridlock.